泡泡玛特回购数量140.00万股，回购金额2.51亿港元，回购最高价为181.200港元，最低价为177.700港 元，年内累计回购金额2.51亿港元；小米集团-W回购数量400.00万股，回购金额1.46亿港元，回购最高 价为36.520港元，最低价为36.360港元，年内累计回购金额16.06亿港元；舜宇光学科技回购数量122.00 万股，回购金额7881.18万港元，回购最高价为65.000港元，最低价为64.200港元，年内累计回购金额 5.36亿港元。 以金额进行统计，1月19日回购金额最多的是泡泡玛特，回购金额为2.51亿港元；其次是小米集团-W， 回购金额为1.46亿港元；回购金额居前的还有舜宇光学科技、快手-W等。回购数量上看，1月19日回购 股数最多的是首程控股，当日回购量为400.00万股；其次是小米集团-W、捷利交易宝等，回购数量分 别为400.00万股、200.00万股。（数据宝） | 02598 | 连连数字 | 13.40 | 90.70 | 6.820 | 6.710 | 871.22 | | --- | --- | --- | --- | --- | --- | --- | | ...

Group 1 - On January 19, a total of 44 Hong Kong stocks were repurchased by companies, with 4 stocks having repurchase amounts exceeding 10 million HKD [1] - The companies with the largest repurchase amounts on January 19 were Pop Mart, Xiaomi Group-W, and Sunny Optical Technology, with repurchase amounts of 251 million HKD, 146 million HKD, and 78.81 million HKD respectively [1] - As of January 19, 102 Hong Kong stocks have been repurchased this year, with 6 stocks having cumulative repurchase amounts exceeding 100 million HKD [1] Group 2 - The companies with the highest cumulative repurchase amounts this year are Tencent Holdings, Xiaomi Group-W, and Sunny Optical Technology, with repurchase amounts of 6.358 billion HKD, 1.606 billion HKD, and 536 million HKD respectively [1]

Group 1 - The core point of the article is that Zhejiang Sunny Optical Co., Ltd. has obtained a patent for an imaging system, with the authorization announcement number CN118625483B, and the application date is March 2023 [1] - Zhejiang Sunny Optical Co., Ltd. was established in 2001 and is located in Ningbo City, primarily engaged in the manufacturing of instruments and meters [1] - The company has a registered capital of 643 million RMB and has made investments in 21 enterprises, participated in 47 bidding projects, and holds 4040 patent records [1] Group 2 - Additionally, the company possesses 21 administrative licenses according to data from Tianyancha [1]

Group 1: Major Developments - 康耐特光学 (02276) and 歌尔光学 plan to establish a joint venture to expand the application market for customized lenses in AI/AR/VR/MR glasses [1] - 圣贝拉 (02508) and 云迹科技 signed a strategic cooperation framework agreement to explore the deep integration and application of artificial intelligence and robotics in high-demand home care scenarios [1] - KKCG Maritime intends to initiate a voluntary conditional partial public acquisition offer to acquire 15.4% of 法拉帝 (09638) shares [1] - 远大医药 (00512) announced that the new drug application for the innovative radiolabeled drug TLX591-CDx has been accepted by the China National Medical Products Administration [1] - 艾美疫苗 (06660) received approval to conduct clinical trials for a 20-valent pneumococcal polysaccharide conjugate vaccine [1] - 中国东方航空股份 (00670) sold the 凯迪克大厦 in Shanghai and related assets to 东航置业 for approximately 134 million yuan [1] - 佑驾创新 (02431) signed a memorandum of understanding with India's leading automotive parts manufacturer STL [1] - 南山铝业国际 (02610) plans to develop electrolytic aluminum and related raw materials and supporting businesses [1] Group 2: Financial Performance - 顺丰控股 (06936) reported a total revenue of 27.339 billion yuan from its express logistics, supply chain, and international businesses in December, representing a year-on-year increase of 3.41% [2] - 美丽田园医疗健康 (02373) issued a profit warning, expecting adjusted net profit for 2025 to be no less than 380 million yuan, a year-on-year increase of at least 40% [2] - 中国太平 (00966) issued a profit warning, anticipating a year-on-year increase of approximately 215% to 225% in shareholder profit for the 2025 fiscal year [2] - 吉宏股份 (02603) issued a profit warning, expecting a net profit attributable to shareholders of approximately 273 million to 291 million yuan for 2025, a year-on-year increase of 50% to 60% [2] - 兖煤澳大利亚 (03668) reported a fourth-quarter coal sales volume of 10.8 million tons, a year-on-year increase of 4% [2] - 兖矿能源 (01171) reported a fourth-quarter commodity coal production of 46.51 million tons, a year-on-year increase of 4.4% [2] - 深圳控股 (00604) projected a total contract sales amount of approximately 13.311 billion yuan for 2025, a year-on-year decrease of 21.55% [2] - 上海石油化工股份 (00338) issued a profit warning, expecting a net loss attributable to shareholders of approximately 1.289 billion to 1.576 billion yuan for 2025, indicating a shift from profit to loss [2] - 上海石油化工股份 (00338) reported gasoline sales revenue of 24.656 billion yuan for 2025 [2]

Group 1 - The company, Sunny Optical Technology (02382), announced a share buyback plan, intending to repurchase 1.22 million shares at a cost of HKD 78.812 million [1]

Group 1 - The company, Sunny Optical Technology (02382.HK), announced a share buyback on January 19, 2026, costing HKD 78.8118 million to repurchase 1.22 million shares [1] - The buyback price ranged from HKD 64.2 to HKD 65 per share [1]

FF305 FF305 確認 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 舜宇光學科技(集團)有限公司 呈交日期： 2026年1月19日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02382 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | 事件 | | | 已發行股份（不包括庫 ...

Summary of Key Points Core Viewpoint - On January 16, 44 Hong Kong-listed companies conducted share buybacks, totaling 31.23 million shares and an aggregate amount of HKD 426 million [1]. Group 1: Buyback Details - Xiaomi Group-W repurchased 5.90 million shares for HKD 219.14 million, with a highest price of HKD 37.200 and a lowest price of HKD 37.080, bringing its year-to-date buyback total to HKD 1.45972 billion [2]. - Sunny Optical Technology repurchased 1.13 million shares for HKD 74.89 million, with a highest price of HKD 66.600 and a lowest price of HKD 65.900, accumulating a year-to-date buyback total of HKD 457.32 million [2]. - Xiansheng Pharmaceutical repurchased 4.43 million shares for HKD 51.63 million, with a highest price of HKD 11.773 and a lowest price of HKD 11.520, totaling HKD 93.58 million in year-to-date buybacks [2]. Group 2: Ranking by Buyback Amount - The highest buyback amount on January 16 was from Xiaomi Group-W at HKD 219.14 million, followed by Sunny Optical Technology at HKD 74.89 million [1]. - Other notable buybacks included Xiansheng Pharmaceutical and Juzhibio, with significant amounts as well [1]. Group 3: Ranking by Buyback Volume - Xiaomi Group-W led in buyback volume with 5.90 million shares, followed by Dingdang Health with 5.21 million shares and Xiansheng Pharmaceutical with 4.43 million shares [1].

Group 1 - The article reports on stock buybacks conducted by various companies on January 16, 2026, with Xiaomi Group-W (01810) having the largest buyback amount of 219 million yuan for 5.90 million shares [1][2] - Other notable buybacks include Sunyu Optical Technology (02382) with 1.13 million shares repurchased for approximately 74.9 million yuan and Xiansheng Pharmaceutical (02096) with 4.43 million shares for about 51.6 million yuan [1][2] - The total number of shares repurchased by Xiaomi Group-W represents 0.71% of its total share capital, while Sunyu Optical Technology's buyback accounts for 0.64% of its total share capital [2][3] Group 2 - The buyback activity reflects a trend among companies to return capital to shareholders, with several companies like Country Garden Services (06098) and Baidu-W (02423) also engaging in significant buybacks [1][2] - The buyback amounts and share counts vary significantly across companies, with some like Weigao Group (01066) and Yunda Automotive (03669) showing higher percentages of total share capital repurchased, at 6.68% and 1.27% respectively [2][3] - The data indicates a diverse range of industries participating in buybacks, including technology, healthcare, and consumer services, suggesting a broad interest in enhancing shareholder value across sectors [1][2]

Core Viewpoint - The statement from a Japanese economist regarding China's inability to mass-produce lithography machines due to a lack of "core materials" reflects a sense of superiority and outdated thinking about China's capabilities in the semiconductor industry [1][8]. Group 1: Market Dynamics - The global photoresist market has been dominated by Japanese companies such as JSR, Tokyo Ohka, and Shin-Etsu Chemical, particularly in high-end ArF and EUV photoresists [3]. - Chinese company Tongcheng New Materials has achieved certification for its ArF/ArFi photoresist products from domestic chip manufacturers and secured mass production orders, projecting nearly 200 million yuan in revenue for 2025, with a growth rate exceeding 50% [3][5]. - Tongcheng New Materials has captured over 40% market share in the KrF photoresist sector and won 35% of the annual orders from Yangtze Memory Technologies [5]. Group 2: Technological Advancements - Nanda Optoelectronics has also received certification for its ArF photoresist from Yangtze Memory Technologies, with domestic production rates increasing from less than 1% in 2023 to over 5% [6]. - Chinese companies like Lante Optics and Sunny Optical have made significant advancements in optical lens materials, establishing themselves as key players in automotive and consumer electronics, although they still lag behind in high-end lithography lenses [6]. Group 3: Structural Changes in Supply Chain - The Japanese economist's comments reveal a failure to recognize the structural changes occurring in the global semiconductor supply chain, particularly as the U.S., Japan, and the Netherlands impose technology restrictions on China [8]. - These restrictions have inadvertently accelerated the efforts of Chinese companies to overcome critical supply chain challenges, leading to a shift in market dynamics [8][11]. - The notion of "soul materials" being irreplaceable is challenged by historical precedents where technological monopolies have been disrupted [10]. Group 4: Future Outlook - The Japanese semiconductor industry's past dominance has been challenged by competitors from South Korea and Taiwan, suggesting that similar shifts could occur in the materials sector [10]. - While China still needs time to catch up in high-end photoresists and specialty optical materials, the assertion that it can "never mass-produce" is overly absolute and reflects emotional bias rather than technical analysis [10]. - The ongoing development of Shanghai Microelectronics' 28nm lithography machine and plans for EUV equipment delivery by 2026 indicate a synchronized advancement in both equipment and materials within the industry [10].